61404-52-2 Usage
Uses
Used in Pharmaceutical Industry:
2-oxo-3-(3,4,5-trimethoxyphenyl)propanoic acid is used as an intermediate in the synthesis of various pharmaceuticals for its potential pharmacological properties. Its chemical structure allows for versatile chemical interactions and reactivity, making it a promising candidate for the development of new drugs.
Used in Organic Synthesis:
2-oxo-3-(3,4,5-trimethoxyphenyl)propanoic acid is used as a building block in the production of other organic compounds due to its unique structure and functional groups. This makes it a valuable component in the synthesis of a wide range of organic molecules for various applications.
Used in Antioxidant and Anti-inflammatory Applications:
2-oxo-3-(3,4,5-trimethoxyphenyl)propanoic acid is used as an antioxidant and anti-inflammatory agent for its potential pharmacological properties. Its ability to combat oxidative stress and reduce inflammation may contribute to the development of treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 61404-52-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,4,0 and 4 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 61404-52:
(7*6)+(6*1)+(5*4)+(4*0)+(3*4)+(2*5)+(1*2)=92
92 % 10 = 2
So 61404-52-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H14O6/c1-16-9-5-7(4-8(13)12(14)15)6-10(17-2)11(9)18-3/h5-6H,4H2,1-3H3,(H,14,15)
61404-52-2Relevant academic research and scientific papers
Potent, selective tetrahydro-β-carboline antagonists of the serotonin 2B (5HT(2B)) contractile receptor in the rat stomach fundus
Audia, James E.,Evrard, Deborah A.,Murdoch, Gwyn R.,Droste, James J.,Nissen, Jeffrey S.,Schenck, Kathy W.,Fludzinski, Pawel,Lucaites, Virginia L.,Nelson, David L.,Cohen, Marlene L.
, p. 2773 - 2780 (2007/10/03)
A series of potent, selective 5HT(2B) receptor antagonists has been identified based upon yohimbine, with SAR studies resulting in a 1000-fold increase in 5HT(2B) receptor affinity relative to the starting structure (- log K(B)s > 10.0 have been obtained). These high-affinity tetrahydro-β- carboline antagonists are able to discriminate among the 5HT2 family of serotonin receptors, with members of the series showing selectivities of more than 100-fold versus both the 5HT(2A) and 5HT(2C) receptors based upon radioligand binding and functional assays. As the first compounds reported with such selectivity and enhanced receptor affinity, these tetrahydro-β- carboline antagonists are useful tools for elucidating the role of serotonin acting at the 5HT(2B) receptor in normal and disease physiology.